Nutritional support during treatment for advanced GI cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special nutritional drink can help people with advanced gastrointestinal cancer better tolerate their first chemotherapy or other systemic treatment, possibly reducing side effects and improving quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of advanced gastrointestinal cancer (such as stomach, colon, or liver).
- You must be about to start your first systemic treatment (like chemotherapy) for advanced disease.
- You must be able to take a nutritional drink by mouth.
- You must be willing to give blood samples for research.
- You must be in fairly good physical condition (able to care for yourself) and have a life expectancy of at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a nutritional supplement drink can help people with cancer who are at risk of not getting enough nutrients. It aims to see if the supplement supports strength and well-being during cancer treatment.
This trial tests whether providing extra nutritional support to people with advanced lung cancer before they start their first chemotherapy or other treatment can improve their health. The goal is to see if good nutrition helps patients tolerate treatment better and maintain their strength.
This trial tests a special liquid supplement for patients with head, neck, lung, rectal, or esophageal cancer who are having radiation and are malnourished or at risk. The supplement is designed to be easier to digest if you have stomach or gut issues.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
This study tests whether a special nutritional drink can help people with pancreatic cancer stay stronger and cope better with chemotherapy. It is for those starting their first chemotherapy treatment.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.